Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11

Phase 4CompletedNCT00015301

National Institute on Drug Abuse (NIDA)

Overview

The purpose of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.

The objective of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.

Study Type

INTERVENTIONAL

Purpose

DIAGNOSTIC

Masking

DOUBLE

Conditions

Interventions

MethylphenidateDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: Healthy normals Exclusion Criteria: History of head trauma or loss of consciousness. Significant medical history. History of seizures.

Locations (1)

New York MDRU

New York, New York, United States

Outcomes

Primary Outcomes

Dopamine receptor availability

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.